Authors:
RAHMAN Z
KAVANAGH J
CHAMPLIN R
GILES R
HANANIA E
FU SQ
ZU ZF
MEHRA R
HOLMES F
KUDELKA A
CLAXTON D
VERSCHRAEGEN C
GAJEWSKI J
ANDREEFF M
HEIMFELD S
BERENSON R
ELLERSON D
CALVERT L
MECHETNER E
HOLZMAYER T
DAYNE A
HAMER J
BACHIER C
OSTROVE J
PRZEPIORKA D
BURTNESS B
COTE R
BAST R
HORTOBAGYI G
DEISSEROTH A
Citation: Z. Rahman et al., CHEMOTHERAPY IMMEDIATELY FOLLOWING AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PATIENTS WITH ADVANCED BREAST-CANCER, Clinical cancer research, 4(11), 1998, pp. 2717-2721
Authors:
HICKSTEIN H
KORTEN G
BAST R
BARZ D
TEMPLIN R
SCHNEIDEWIND JM
KITTNER C
NIZZE H
SCHMIDT R
Citation: H. Hickstein et al., PROTEIN-A IMMUNOADSORPTION (IA) IN RENAL-TRANSPLANTATION PATIENTS WITH VASCULAR REJECTION, Transfusion science, 19, 1998, pp. 53-57
Authors:
HICKSTEIN H
KORTEN G
BAST R
BARZ D
TEMPLIN R
SCHNEIDEWIND JM
KITTNER CH
NIZZE H
SCHMIDT R
Citation: H. Hickstein et al., PROTEIN-A IMMUNOADSORPTION (IA) IN RENAL-TRANSPLANTATION PATIENTS WITH VASCULAR REJECTION (VOL 19, PG 53, 1998), Transfusion science, 19(1), 1998, pp. 107-107
Authors:
GAJEWSKI J
RONDON G
MIRZA N
MEHRA R
DONATO M
ANDERLINI P
KORBLING M
THERIALT R
KHOURI I
GIRALT S
BUZDAR A
UENO N
PRZEPIORKA D
ANDERSSON B
DURRETT A
SALIBA R
BRUTON J
RAHMAN Z
IPPOLITI C
HORTABAQYI G
RABER M
BAST R
CHAMPLIN R
Citation: J. Gajewski et al., PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL COMPARING INTENSIVE CHEMOTHERAPY WITH GROWTH-FACTOR (GF) OR PERIPHERAL-BLOOD PROGENITOR (PBPC) CELL MOBILIZATION TO GROWTH-FACTOR ALONE FOR HEMATOPOIETIC RESCUE AFTER HIGH-DOSE CHEMOTHERAPY (HDC), Experimental hematology, 26(8), 1998, pp. 371-371
Authors:
WACKE R
BAST R
ROHDE B
PRALL F
SEITER H
DREWELOW B
Citation: R. Wacke et al., PHARMACOKINETIC STUDIES OF ORAL AND INTRAVENOUS CYCLOSPORINE IN PREKIDNEY TRANSPLANT PATIENT, Transplantation proceedings, 30(5), 1998, pp. 1663-1663
Authors:
WACKE R
MUNDKOWSKI R
ROHDE B
PRALL F
BAST R
SEITER H
DREWELOW B
Citation: R. Wacke et al., INDIVIDUAL PHARMACOKINETICS OF CYCLOSPORINE IN PRE-KIDNEY TRANSPLANT PATIENTS, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 689-689
Authors:
HANANIA EG
GILES RE
KAVANAGH J
ELLERSON D
ZU Z
WANG T
SU Y
KUDELKA A
RAHMAN Z
HOLMES F
HORTOBAGYI G
CLAXTON D
BACHIER C
THALL P
CHENG S
HESTER J
OSTROVE JM
BIRD RE
CHANG A
KORBLING M
SEONG D
COTE R
HOLZMAYER T
MECHETNER E
HEIMFELD S
BERENSON R
BURTNESS B
EDWARDS C
BAST R
ANDREEFF M
CHAMPLIN R
DEISSEROTH AB
Citation: Eg. Hanania et al., RESULTS OF MDR-1 VECTOR MODIFICATION TRIAL INDICATE THAT GRANULOCYTE MACROPHAGE COLONY-FORMING UNIT CELLS DO NOT CONTRIBUTE TO POSTTRANSPLANT HEMATOPOIETIC RECOVERY FOLLOWING INTENSIVE SYSTEMIC THERAPY/, Proceedings of the National Academy of Sciences of the United Statesof America, 93(26), 1996, pp. 15346-15351
Authors:
DONATO M
MEHRA R
GAJEWSKI J
GERSHENSON D
BAST R
CHAMPLIN R
Citation: M. Donato et al., PHASE I-II STUDY OF 4 COURSES HIGH-DOSE PACLITAXEL AND CARBOPLATIN WITH PERIPHERAL-BLOOD STEM-CELL (PBSC) FOR SALVAGE TREATMENT OF OVARIAN-CANCER, Blood, 88(10), 1996, pp. 3858-3858
Citation: R. Bast et R. Woolas, SCREENING FOR OVARIAN-CANCER - MULTIPLE MARKERS MAY OUTPERFORM CA-125ALONE, BMJ. British medical journal, 306(6893), 1993, pp. 1684-1685